Novartis AG (LON:0K9E)
London · Delayed Price · Currency is GBP · Price in USD 148.88
-0.61 (-0.41%)
At close: Jan 30, 2026
Novartis AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 14,393 | 11,941 | 14,850 | 6,955 | 24,021 | 8,072 |
Depreciation & Amortization | 4,734 | 4,599 | 5,135 | 4,994 | 4,949 | 5,110 |
Loss (Gain) From Sale of Assets | -17 | -74 | -180 | -308 | -646 | -478 |
Asset Writedown & Restructuring Costs | 668 | 1,470 | 3,142 | 1,711 | 648 | 1,354 |
Loss (Gain) From Sale of Investments | -3 | 45 | 106 | 260 | -14,638 | -335 |
Loss (Gain) on Equity Investments | 13 | 38 | 13 | 11 | -214 | -673 |
Stock-Based Compensation | 1,069 | 1,044 | 865 | 791 | 700 | 738 |
Other Operating Activities | 1,249 | 369 | -7,808 | 195 | -607 | 2,590 |
Change in Accounts Receivable | -868 | -931 | -1,504 | -397 | -352 | 137 |
Change in Inventory | -286 | -225 | -546 | -560 | -102 | -543 |
Change in Accounts Payable | 180 | -105 | 479 | -181 | -111 | -324 |
Change in Other Net Operating Assets | -59 | -552 | -332 | -432 | -283 | -1,998 |
Operating Cash Flow | 21,073 | 17,619 | 14,458 | 14,236 | 15,071 | 13,650 |
Operating Cash Flow Growth | 31.93% | 21.86% | 1.56% | -5.54% | 10.41% | 0.18% |
Capital Expenditures | -1,497 | -1,366 | -1,060 | -916 | -1,066 | -1,275 |
Sale of Property, Plant & Equipment | 59 | 86 | 237 | 158 | 211 | 88 |
Cash Acquisitions | -552 | -4,018 | -3,561 | -832 | -259 | -10,006 |
Divestitures | 85 | 107 | 3 | -8 | 54 | 49 |
Sale (Purchase) of Intangibles | -2,428 | -2,368 | 262 | -1,153 | -804 | -930 |
Investment in Securities | -627 | 43 | 10,838 | 4,656 | 6,816 | -922 |
Other Investing Activities | -846 | 3 | -1,123 | -437 | -744 | -186 |
Investing Cash Flow | -5,806 | -7,513 | 5,596 | 1,468 | 4,208 | -13,182 |
Short-Term Debt Issued | - | 958 | 546 | 252 | - | 2,261 |
Long-Term Debt Issued | - | 6,143 | - | - | - | 7,126 |
Total Debt Issued | 953 | 7,101 | 546 | 252 | - | 9,387 |
Short-Term Debt Repaid | - | -289 | - | - | -3,547 | - |
Long-Term Debt Repaid | - | -2,422 | -2,481 | -2,837 | -2,440 | -2,315 |
Total Debt Repaid | -1,912 | -2,711 | -2,481 | -2,837 | -5,987 | -2,315 |
Net Debt Issued (Repaid) | -959 | 4,390 | -1,935 | -2,585 | -5,987 | 7,072 |
Issuance of Common Stock | 23 | 30 | 153 | 100 | 53 | 748 |
Repurchase of Common Stock | -10,494 | -8,331 | -8,719 | -10,652 | -3,057 | -2,842 |
Common Dividends Paid | -7,818 | -7,624 | -7,255 | -7,506 | -7,368 | -6,987 |
Other Financing Activities | -298 | -207 | 3,478 | 81 | 95 | -199 |
Financing Cash Flow | -19,546 | -11,742 | -14,278 | -20,562 | -16,264 | -2,208 |
Foreign Exchange Rate Adjustments | 226 | -298 | 100 | -32 | -266 | 286 |
Net Cash Flow | -4,053 | -1,934 | 5,876 | -4,890 | 2,749 | -1,454 |
Free Cash Flow | 19,576 | 16,253 | 13,398 | 13,320 | 14,005 | 12,375 |
Free Cash Flow Growth | 32.64% | 21.31% | 0.59% | -4.89% | 13.17% | 1.05% |
Free Cash Flow Margin | 34.73% | 31.42% | 28.71% | 30.65% | 31.85% | 24.80% |
Free Cash Flow Per Share | 9.92 | 7.99 | 6.40 | 6.06 | 6.20 | 5.39 |
Cash Interest Paid | 984 | 855 | 751 | 667 | 643 | 703 |
Cash Income Tax Paid | 2,505 | 2,258 | 2,787 | 1,702 | 1,856 | 1,833 |
Levered Free Cash Flow | 16,009 | 12,038 | 12,133 | 7,311 | 11,774 | 11,557 |
Unlevered Free Cash Flow | 16,706 | 12,667 | 12,667 | 7,811 | 12,266 | 12,100 |
Change in Working Capital | -1,033 | -1,813 | -1,903 | -1,570 | -848 | -2,728 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.